These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11867881)

  • 41. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.
    Rusanen H; Saarinen JT; Sillanpää N
    Cerebrovasc Dis; 2015; 39(2):130-7. PubMed ID: 25660943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis.
    Kharitonova TV; Melo TP; Andersen G; Egido JA; Castillo J; Wahlgren N;
    Stroke; 2013 Sep; 44(9):2513-8. PubMed ID: 23881960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms.
    Amaro S; Cánovas D; Castellanos M; Gállego J; Martí-Fèbregas J; Segura T; Chamorro A
    Int J Stroke; 2010 Aug; 5(4):325-8. PubMed ID: 20636718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Admission hyperglycaemia and cerebral perfusion deficits in acute ischaemic stroke.
    Luitse MJ; van Seeters T; Horsch AD; Kool HA; Velthuis BK; Kappelle LJ; Biessels GJ
    Cerebrovasc Dis; 2013; 35(2):163-7. PubMed ID: 23429063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prior use of antiplatelet therapy can be associated with a higher chance for early recanalization of the occluded middle cerebral artery in acute stroke patients treated with intravenous thrombolysis.
    Saňák D; Kuliha M; Herzig R; Roubec M; Skoloudík D; Zapletalová J; Köcher M; Král M; Veverka T; Cecháková E; Bártková A; Procházka V; Kaňovský P
    Eur Neurol; 2012; 67(1):52-6. PubMed ID: 22156368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CT-angiographic collateralization predicts final infarct volume after intra-arterial thrombolysis for acute anterior circulation ischemic stroke.
    Angermaier A; Langner S; Kirsch M; Kessler C; Hosten N; Khaw AV
    Cerebrovasc Dis; 2011; 31(2):177-84. PubMed ID: 21135554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke.
    Aries MJ; Uyttenboogaart M; Koopman K; Rödiger LA; Vroomen PC; De Keyser J; Luijckx GJ
    J Neurol Sci; 2009 Oct; 285(1-2):114-7. PubMed ID: 19576595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
    Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
    Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men.
    Arenillas JF; Sandoval P; Pérez de la Ossa N; Millán M; Guerrero C; Escudero D; Dorado L; López-Cancio E; Castillo J; Dávalos A
    Stroke; 2009 Feb; 40(2):344-9. PubMed ID: 19109538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial.
    Southerland AM; Johnston KC
    Ann N Y Acad Sci; 2012 Sep; 1268(1):72-8. PubMed ID: 22994224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delayed increase in infarct volume after cerebral ischemia: correlations with thrombolytic treatment and clinical outcome.
    Pantano P; Caramia F; Bozzao L; Dieler C; von Kummer R
    Stroke; 1999 Mar; 30(3):502-7. PubMed ID: 10066843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognosis of aphasia in stroke patients early after iv thrombolysis.
    Kremer C; Perren F; Kappelin J; Selariu E; Abul-Kasim K
    Clin Neurol Neurosurg; 2013 Mar; 115(3):289-92. PubMed ID: 22738732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of acute ischemic brain infarction with the assistance of local intraarterial thrombolysis with recombinant tissue-type plasminogen activator.
    Poncyljusz W; Falkowski A; Kojder I; Cebula E; Sagan L; Czechowski J; Walecka A
    Acta Radiol; 2007 Sep; 48(7):774-80. PubMed ID: 17729010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy.
    Yoo AJ; Chaudhry ZA; Nogueira RG; Lev MH; Schaefer PW; Schwamm LH; Hirsch JA; González RG
    Stroke; 2012 May; 43(5):1323-30. PubMed ID: 22426317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined full-dose IV and endovascular thrombolysis in acute ischaemic stroke.
    Bhatia R; Shobha N; Menon BK; Bal SP; Kochar P; Palumbo V; Wong JH; Morrish WF; Hudon ME; Hu W; Coutts SB; Barber PA; Watson T; Goyal M; Demchuk AM; Hill MD
    Int J Stroke; 2014 Dec; 9(8):974-9. PubMed ID: 23013039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke.
    Heiss WD; Grond M; Thiel A; von Stockhausen HM; Rudolf J; Ghaemi M; Löttgen J; Stenzel C; Pawlik G
    J Cereb Blood Flow Metab; 1998 Dec; 18(12):1298-307. PubMed ID: 9850142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
    Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
    Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.